ACADIA Pharmaceuticals, Inc. (ACAD)
21.48
-0.87
(-3.89%)
USD |
NASDAQ |
May 06, 16:00
21.00
-0.48
(-2.23%)
After-Hours: 07:05
ACADIA Pharmaceuticals Free Cash Flow : 6.308M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Insmed, Inc. | -997.58M |
| Madrigal Pharmaceuticals, Inc. | -275.41M |
| Merck & Co., Inc. | 14.12B |
| BioMarin Pharmaceutical, Inc. | 759.12M |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -48.73M |
| Cash from Investing (Quarterly) | -55.87M |
| Cash from Financing (Quarterly) | 22.67M |
| Free Cash Flow Per Share (Quarterly) | -0.3078 |
| Free Cash Flow to Equity (Quarterly) | -50.11M |
| Free Cash Flow to Firm (Quarterly) | -52.74M |
| Free Cash Flow Yield | 0.17% |